Previous 10 | Next 10 |
Image source: The Motley Fool. ViewRay, Inc. (NASDAQ: VRAY) Q2 2022 Earnings Call Aug 02, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ViewRay, Inc. (VRAY) Q2 2022 Earnings Call Transcript
ViewRay, Inc. (VRAY) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Matt Harrison - Director, IR Scott Drake - President & CEO Zach Stassen - CFO Conference Call Participants Rick Wise - Stifel Sam Eiber - LDR ...
The following slide deck was published by ViewRay, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: ViewRay, Inc. 2022 Q2 - Results - Earnings Call Presentation
ViewRay press release ( NASDAQ: VRAY ): Q2 GAAP EPS of -$0.15 in-line. Revenue of $22.15M (+47.7% Y/Y) beats by $3.24M . For further details see: ViewRay GAAP EPS of -$0.15 in-line, revenue of $22.15M beats by $3.24M
ViewRay Announces Second Quarter 2022 Results PR Newswire CLEVELAND , Aug. 2, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Hi...
ViewRay and Katie Couric Media Partner to Raise Awareness about MRIdian® MRI-Guided Radiation Therapy PR Newswire Multiyear campaign will highlight clinical evidence and patient impact of MRIdian for cancer treatment CLEVELAND , Aug. 2, 2022 ...
Centre Oscar Lambret Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System PR Newswire Represents the first in Lille, France to Bring the Benefits of Precision Radiation Therapy to the Hauts de France Region CLEVELAND , July 29, 2022...
ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model looks to “Grow Markets and Take Market Share” targeting an ...
Saitama Medical University International Medical Center Selects MRIdian® MRI-Guided Radiation Therapy System PR Newswire CLEVELAND , July 19, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that Saitama Medical University Inter...
ViewRay Announces Conference Call for Second Quarter 2022 Financial Results to be Held After Market on August 2, 2022 PR Newswire CLEVELAND , July 19, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release o...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...